Teipel, Stefan, Drzezga, Alexander, Grothe, Michel J. ORCID: 0000-0003-2600-9022, Barthel, Henryk, Chetelat, Gale, Schuff, Norbert, Skudlarski, Pawel, Cavedo, Enrica, Frisoni, Giovanni B., Hoffmann, Wolfgang, Thyrian, Jochen Rene ORCID: 0000-0001-6889-693X, Fox, Chris ORCID: 0000-0001-9480-5704, Minoshima, Satoshi ORCID: 0000-0002-0043-3047, Sabri, Osama ORCID: 0000-0002-6425-3504 and Fellgiebel, Andreas (2015). Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection. Lancet Neurol., 14 (10). S. 1037 - 1054. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-4465

Full text not available from this repository.

Abstract

Alzheimer's disease is a progressive neurodegenerative disease that typically manifests clinically as an isolated amnestic deficit that progresses to a characteristic dementia syndrome. Advances in neuroimaging research have enabled mapping of diverse molecular, functional, and structural aspects of Alzheimer's disease pathology in ever increasing temporal and regional detail. Accumulating evidence suggests that distinct types of imaging abnormalities related to Alzheimer's disease follow a consistent trajectory during pathogenesis of the disease, and that the first changes can be detected years before the disease manifests clinically. These findings have fuelled clinical interest in the use of specific imaging markers for Alzheimer's disease to predict future development of dementia in patients who are at risk. The potential clinical usefulness of single or multimodal imaging markers is being investigated in selected patient samples from clinical expert centres, but additional research is needed before these promising imaging markers can be successfully translated from research into clinical practice in routine care.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Teipel, StefanUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Drzezga, AlexanderUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Grothe, Michel J.UNSPECIFIEDorcid.org/0000-0003-2600-9022UNSPECIFIED
Barthel, HenrykUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Chetelat, GaleUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schuff, NorbertUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Skudlarski, PawelUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Cavedo, EnricaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Frisoni, Giovanni B.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hoffmann, WolfgangUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Thyrian, Jochen ReneUNSPECIFIEDorcid.org/0000-0001-6889-693XUNSPECIFIED
Fox, ChrisUNSPECIFIEDorcid.org/0000-0001-9480-5704UNSPECIFIED
Minoshima, SatoshiUNSPECIFIEDorcid.org/0000-0002-0043-3047UNSPECIFIED
Sabri, OsamaUNSPECIFIEDorcid.org/0000-0002-6425-3504UNSPECIFIED
Fellgiebel, AndreasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-392157
DOI: 10.1016/S1474-4422(15)00093-9
Journal or Publication Title: Lancet Neurol.
Volume: 14
Number: 10
Page Range: S. 1037 - 1054
Date: 2015
Publisher: ELSEVIER SCIENCE INC
Place of Publication: NEW YORK
ISSN: 1474-4465
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
MILD COGNITIVE IMPAIRMENT; POSITRON-EMISSION-TOMOGRAPHY; TEMPORAL-LOBE ATROPHY; PITTSBURGH COMPOUND-B; FIBRILLAR AMYLOID-BETA; SHORT-TERM CONVERSION; CEREBROSPINAL-FLUID; HIPPOCAMPAL VOLUME; FOLLOW-UP; PROBABILISTIC PREDICTIONMultiple languages
Clinical NeurologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/39215

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item